SAN DIEGO, Dec. 28, 2020 /PRNewswire/ — Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce the Company’s latest acquisition and letters of intent to acquire existing businesses that accelerate its 2021 global market expansion … […]
SAN DIEGO, Dec. 28, 2020 /PRNewswire/ — Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce the Company’s latest acquisition and letters of intent to acquire existing businesses that accelerate its 2021 global market expansion … […]
SAN DIEGO, Dec. 15, 2020 /PRNewswire/ — Dalrada Financial Corp. (OTC Pink: DFCO, “Dalrada”) would like to update its shareholders and the public on the Company’s intellectual property holdings and filings, as the Company is undergoing rapid growth… […]
SAN DIEGO and MARSEILLE, France, Oct. 27, 2020 /PRNewswire/ — Shareholder rights law firm Robbins LLP announces it is investigating whether certain officers and directors of Innate Pharma S.A. (NASDAQ: IPHA) violated federal securities laws. Innate… […]
SAN DIEGO, Sept. 8, 2020 /PRNewswire/ — Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve patient outcomes, announces it has entere… […]
Bridgewest to develop the site into a full-service Contract Development and Manufacturing Organization
SAN DIEGO and ADELAIDE, Australia, Sept. 1, 2020 /PRNewswire/ — The Bridgewest Group, a premier private investment company that focuses on disrupt… […]
Apricorn’s 4th Generation Flash Key is awarded NIST’s highest level of FIPS validation granted to portable data storage devices.
POWAY, Calif., Aug. 27, 2020 /PRNewswire/ — Apricorn, the leading manufacturer of software-free, 256-bit AES XTS hardwar… […]
The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines
SINGAPORE and SAN DIEGO, Aug. 12, 2020 /PRNewswire/ — ImmunoSc… […]
CARLSBAD, Calif., Aug. 2, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $1… […]
Conference call scheduled for 4:30 p.m. ET today- Enrollment Continues in Phase 2b VOYAGE Study of VK2809 in NASH; New Data from 12-Week Phase 2 Trial to be Highlighted at EASL- IND Filed for VK0214 in X-ALD; Phase 1 Trial Expected to Begin Q3 2020- Ba… […]
Copyright © 2021 | MH Magazine WordPress Theme by MH Themes
